← Evidence map

ArticleJournal of arrhythmia2025

Reply to "Challenges to the Long-Term Safety Claims of Extremely Low-Dose Amiodarone: Pulmonary, Thyroid, Hepatic, and Statistical Concerns".

Kentaro YoshidaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Reply to "Challenges to the Long-Term Safety Claims of Extremely Low-Dose Amiodarone: Pulmonary, Thyroid, Hepatic, and Statistical Concerns". | OpenQuestion